Evidence map›Paper›PMID 29844356›Full record

ArticleScientific reports2018

Niche-induced extramedullary hematopoiesis in the spleen is regulated by the transcription factor Tlx1.

Akihisa Oda, Toshiki Tezuka, Yuta Ueno, Shoko Hosoda, Yusuke Amemiya, Chihiro Notsu, Toru Kasahara, Chiharu Nishiyama, Ryo Goitsuka

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Stem Cell Niche Concept: Search for Current Expert Consensus.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Extramedullary hematopoiesis in cancer.Experimental & molecular medicine · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Glucose Metabolism and Aging of Hematopoietic Stem and Progenitor Cells.International journal of molecular sciences · 2022
    Review
  20. OralFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Akihisa OdaDivision of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
Toshiki TezukaDivision of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
Yuta UenoDivision of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
Shoko HosodaDivision of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
Yusuke AmemiyaDivision of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
Chihiro NotsuDivision of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
Toru KasaharaDivision of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
Chiharu NishiyamaLaboratory of Molecular Biology and Immunology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo, Japan.ORCID 0000-0002-4082-9097
Ryo GoitsukaDivision of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan. ryogoi@rs.noda.tus.ac.jp.ORCID 0000-0002-1137-9760
Tokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extramedullary hematopoiesis (EMH) in postnatal life is a pathological process in which the differentiation of hematopoietic stem/progenitor cells (HSPCs) occurs outside the bone marrow (BM) to respond to hematopoietic emergencies. The spleen is a major site for EMH; however, the cellular and molecular nature of the stromal cell components supporting HSPC maintenance, the niche for EMH in the spleen remain poorly understood compared to the growing understanding of the BM niche at the steady-state as well as in emergency hematopoiesis. In the present study, we demonstrate that mesenchymal progenitor-like cells expressing Tlx1, an essential transcription factor for spleen organogenesis, and selectively localized in the perifollicular region of the red pulp of the spleen, are a major source of HSPC niche factors. Consistently, overexpression of Tlx1 in situ induces EMH, which is associated with mobilization of HSPC into the circulation and their recruitment into the spleen where they proliferate and differentiate. The alterations in the splenic microenvironment induced by Tlx1 overexpression in situ phenocopy lipopolysaccharide (LPS)-induced EMH, and the conditional loss of Tlx1 abolished LPS-induced splenic EMH. These findings indicate that activation of Tlx1 expression in the postnatal splenic mesenchymal cells is critical for the development of splenic EMH.

Indexed as

Stem Cell NicheAnimalsCell ProliferationHematopoiesis, ExtramedullaryHomeodomain ProteinsLipopolysaccharidesMiceMice, KnockoutSpleenHomeodomain ProteinsLipopolysaccharidesTlx1 protein, mouse

Identifiers

PMID29844356
PMCPMC5974313
OpenAlexW2807500664

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.